Publication | Closed Access
Urotensin II receptor expression in prostate cancer patients: A new possible marker
11
Citations
14
References
2018
Year
Urotensin II receptor is a potential marker of adverse pathological outcomes. Further studies should confirm our data and evaluate its role as a prognostic marker.
| Year | Citations | |
|---|---|---|
Page 1
Page 1